IP Library Assignment 046105/0125
Patent Assignment
Reel/Frame 046105/0125

Release of Security Interest in Patents

Recorded: 2018-05-04 Pages: 4
Assignor
Assignee
IMPAX LABORATORIES, INC.
2 WALNUT GROVE DRIVE, SUITE 190, HORSHAM, PENNSYLVANIA, 19044
Covered Property (1)
Controlled Release Formulations of Levodopa and Uses Thereof
Patent: 9,533,046 →
Application: 14/958,975 →
Publication: US 2016/0089438
Related Assignments (9)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Mar 2, 2016
From: IMPAX LABORATORIES, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 037869/0622 →
Security Interest Mar 27, 2017
From: IMPAX LABORATORIES, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 041750/0869 →
Release of Security Interest in Patents May 4, 2018
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: IMPAX LABORATORIES, INC.
Reel/Frame 046104/0976 →
Entity Conversion Aug 3, 2018
From: IMPAX LABORATORIES, INC.
To: IMPAX LABORATORIES, LLC
Reel/Frame 046703/0595 →
Patent Security Agreement (Term Loan) May 12, 2022
From: AMNEAL PHARMACEUTICALS LLC; IMPAX LABORATORIES, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 060050/0224 →
Patent Security Agreement Jun 10, 2022
From: AMNEAL PHARMACEUTICALS LLC; IMPAX LABORATORIES, LLC; GEMINI LABORATORIES LLC
To: TRUIST BANK. AS ADMINISTRATIVE AGENT
Reel/Frame 060329/0568 →
Security Interest Nov 17, 2023
From: IMPAX LABORATORIES, LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 065602/0473 →
Release of Security Interest in Patents at R/F 060050/0224 Jan 21, 2025
From: JPMORGAN CHASE BANK, N.A., AS AGENT
To: AMNEAL PHARMACEUTICALS LLC; IMPAX LABORATORIES, LLC
Reel/Frame 069958/0509 →
Patent Security Agreement Aug 1, 2025
From: AMNEAL PHARMACEUTICALS LLC; IMPAX LABORATORIES, LLC; GEMINI LABORATORIES, LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072312/0127 →